HOXA9 promotes glioblastoma initiation, aggressiveness and resistance to therapy

Glioblastoma is the most common and malignant subtype of glioma, exhibiting remarkable resistance to treatment. Here we investigated the oncogenic potential of HOXA9 in gliomagenesis, the molecular and cellular mechanisms by which HOXA9 may render glioblastoma more aggressive, and how HOXA9 affects...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pojo, Marta (author)
Outros Autores: Gonçalves, Céline S. (author), Xavier-Magalhães, Ana (author), Oliveira, Ana Isabel (author), Costa, Sandra Maria Araújo da (author), Pinto, Luísa (author), Reis, R. M. (author), Rocha, Miguel (author), Sousa, Nuno (author), Costa, Bruno Marques (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2014
Assuntos:
Ciências Médicas::Biotecnologia Médica
Texto completo:http://hdl.handle.net/1822/38254
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/38254

Texto Completo

http://hdl.handle.net/1822/38254

Registros relacionados